How does AFRP.N0000's PB Ratio compare to its peers?

Insufficient data to calculate AFRP.N0000's Price-To-Book Ratio vs. peers for valuation analysis.

How does AFRP.N0000's PB Ratio compare vs other companies in the African Pharmaceuticals Industry?

Insufficient data to calculate AFRP.N0000's Price-To-Book Ratio vs. industry for valuation analysis.

What is AFRP.N0000's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate AFRP.N0000's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of AFRP.N0000 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate AFRP.N0000's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

Africure Pharmaceuticals MUSE:AFRP.N0000 Stock Report

Last Price

US$6.06

Market Cap

US$57.1m

7D

0%

1Y

0%

Updated

22 Dec, 2024

Data

Company Financials

Africure Pharmaceuticals Ltd

MUSE:AFRP.N0000 Stock Report

Market Cap: US$57.1m

AFRP.N0000 Stock Overview

Manufactures and distributes pharmaceutical products. More details

AFRP.N0000 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Does not have a meaningful market cap ($57M)

My Notes

Capture your thoughts, links and company narrative

Africure Pharmaceuticals Ltd Competitors

Shedir Pharma Group

BIT:SHE

€55.2m

Sinsin Pharmaceutical

KOSDAQ:A002800

₩81.5b

Tien Liang BioTech

TPEX:4127

NT$1.9b

JW Shinyak

KOSDAQ:A067290

₩84.4b

Price History & Performance

Summary of share price highs, lows and changes for Africure Pharmaceuticals
Historical stock prices
Current Share Price	US$6.06
52 Week High	US$0
52 Week Low	US$0
Beta	0
1 Month Change	0%
3 Month Change	0%
1 Year Change	0%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	0%

Recent News & Updates

Recent updates

Shareholder Returns

	AFRP.N0000	MU Pharmaceuticals	MU Market
7D	0%	1.8%	0.2%
1Y	0%	-7.3%	2.7%

Return vs Industry: AFRP.N0000 exceeded the MU Pharmaceuticals industry which returned -7.3% over the past year.

Return vs Market: AFRP.N0000 underperformed the MU Market which returned 2.7% over the past year.

Price Volatility

Is AFRP.N0000's price volatile compared to industry and market?
AFRP.N0000 volatility
AFRP.N0000 Average Weekly Movement	0%
Pharmaceuticals Industry Average Movement	6.2%
Market Average Movement	3.4%
10% most volatile stocks in MU Market	7.1%
10% least volatile stocks in MU Market	0.8%

Stable Share Price: Data is not available.

Volatility Over Time: Insufficient data to determine AFRP.N0000's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2017	n/a	n/a	www.africurepharma.com

Africure Pharmaceuticals Ltd manufactures and distributes pharmaceutical products. It sells pharmaceutical products in the form of tablets, capsules, and syrup dosages. The company was incorporated in 2017 and is headquartered in Ebene, Mauritius.

Africure Pharmaceuticals Ltd Fundamentals Summary

How do Africure Pharmaceuticals's earnings and revenue compare to its market cap?
AFRP.N0000 fundamental statistics
Market cap	US$57.07m
Earnings (TTM)	US$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is AFRP.N0000 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AFRP.N0000 income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$0
Earnings	US$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did AFRP.N0000 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 08:49
End of Day Share Price	2024/12/20 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Africure Pharmaceuticals Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution